Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver
Open Access
- 22 February 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 43 (3) , 454-463
- https://doi.org/10.1002/hep.21075
Abstract
The hepatoprotective mechanisms of N-acetylcysteine (NAC) in non–acetaminophen-induced liver injury have not been studied in detail. We investigated the possibility that NAC could affect key pathways of hepatocellular metabolism with or without changes in glutathione (GSH) synthesis. Hepatocellular metabolites and high-energy phosphates were quantified from mouse liver extracts by 1H- and 31P-NMR (nuclear magnetic resonance) spectroscopy. 13C-NMR-isotopomer analysis was used to measure [U-13C]glucose metabolism through pyruvate dehydrogenase (PDH) and pyruvate carboxylase (PC). NAC (150-1,200 mg/kg) increased liver concentrations of GSH from 8.60 ± 0.48 to a maximum of 12.95 ± 1.03 μmol/g ww, whereas hypotaurine (HTau) concentrations increased from 0.05 ± 0.02 to 9.95 ± 1.12 μmol/g ww. The limited capacity of NAC to increase GSH synthesis was attributed to impaired glucose metabolism through PC. However, 300 mg/kg NAC significantly increased the fractional 13C-enrichment in Glu (from 2.08% ± 0.26% to 4.00% ± 0.44%) synthesized through PDH, a key enzyme for mitochondrial energy metabolism. This effect could be uncoupled from GSH synthesis and was associated with the prevention of liver injury induced by tert-butylhydroperoxide and 3-nitropropionic acid. In conclusion , NAC (1) has a limited capacity to elevate GSH synthesis; (2) increases HTau formation linearly; and (3) improves mitochondrial tricarboxylic acid (TCA) cycle metabolism by stimulation of carbon flux through PDH. This latter effect is independent of the capacity of NAC to replete GSH stores. These metabolic actions, among other yet unknown effects, are critical for NAC's therapeutic value and should be taken into account when deciding on a wider use of NAC. Supplementary material for this article can be found on the HEPATOLOGY website ( http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html ). (Hepatology 2006;43:454–463.)Keywords
This publication has 33 references indexed in Scilit:
- Metabolic profiles to define the genome: can we hear the phenotypes?Philosophical Transactions Of The Royal Society B-Biological Sciences, 2004
- Acetaminophen-Induced Oxidant Stress and Cell Injury in Cultured Mouse Hepatocytes: Protection by N-Acetyl CysteineToxicological Sciences, 2004
- N‐Acetylcysteine for the Treatment of Clove Oil Induced Fulminant Hepatic Failure: Case Report and Review of the LiteratureJournal of Toxicology: Clinical Toxicology, 2004
- Regulation of glial metabolism studied by 13C‐NMRNMR in Biomedicine, 2003
- Selective increase of brain lactate synthesis in experimental acute liver failure: Results of a [1H-13C] nuclear magnetic resonance studyHepatology, 2003
- The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle FunctionJournal of Biological Chemistry, 2002
- N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunctionCritical Care Medicine, 1997
- 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1994
- Glutamine Preserves Liver Glutathione After Lethal Hepatic InjuryAnnals of Surgery, 1992
- Quantitative analysis of glycogen repletion by nuclear magnetic resonance spectroscopy in the conscious rat.Journal of Clinical Investigation, 1987